证券代码：688170 证券简称：德龙激光 公告编号：2025-017 苏州德龙激光股份有限公司 关于 2024 年度计提资产减值准备的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 本次计提减值准备情况概述 苏州德龙激光股份有限公司（以下简称 "德龙激光" 、"公司"）根据《上海 证券交易所科创板股票上市规则》的相关要求，依据《企业会计准则》以及公司 相关会计政策的规定，为客观公允地反映公司财务状况、资产价值与经营成果， 公司及子公司对各类资产进行减值测试，基于谨慎性原则，对截至 2024 年 12 月 31 日合并报表范围内可能发生信用及资产减值损失的有关资产计提信用及资 产减值准备。 公司本年计提信用减值损失 868.35 万元，计提资产减值损失 4,015.27 万元， 具体如下表： | 单位：万元 | | --- | | 项目 | | 计提及转回金额 | | --- | --- | --- | | 信用减值损失 （损失以"-"号填列） | 应收票据坏账损失 | 74.19 | | | 应收账款坏账损失 ...

证券代码：688170 证券简称：德龙激光 公告编号：2025-015 苏州德龙激光股份有限公司 关于召开2024年度股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 2024年度股东大会 召开日期时间：2025 年 5 月 19 日 14 点 00 分 召开地点：中国（江苏）自由贸易试验区苏州片区苏州工业园区杏林街 98 号德龙激光会议室 一、 召开会议的基本情况 （一） 股东大会类型和届次 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 5 月 19 日 （五） 网络投票的系统、起止日期和投票时间。 重要内容提示： （六） 融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者的投 票，应按照《上海证券交易所科创板上市公司自律监管指引第 1 号 — 规范运作》 等有关规定执行。 （七） 涉及公开征集股东投票权 不涉及 二、 会议审议事项 本次股东大会审议议案及投票股东类型 | 序号 | 议案名称 | 投票 ...

证券代码：688170 证券简称：德龙激光 公告编号：2025-009 苏州德龙激光股份有限公司 关于第五届监事会第六次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 苏州德龙激光股份有限公司（以下简称"公司"、"德龙激光"）第五届监事会 第六次会议于 2025 年 4 月 27 日在公司会议室以现场结合通讯的方式召开，会议 通知已于 2025 年 4 月 17 日通过通讯方式送达各位监事。本次会议由监事会主席 苏金其先生主持，应到监事 3 人，实到监事 3 人。本次会议的召集、召开符合有 关法律、法规及规章制度和《公司章程》的有关规定。 具体内容详见公司于同日在上海证券交易所网站（www.sse.com.cn）披露的 《苏州德龙激光股份有限公司 2024 年年度报告摘要》、《苏州德龙激光股份有限 公司 2024 年年度报告》。 3、 审议通过《关于 2024 年度内部控制评价报告的议案》 监事会认为：公司于内部控制评价报告基准日，不存在财务报告内部控制重 大缺陷，公司已按照企业内部控 ...

证券代码：688170 证券简称：德龙激光 公告编号：2025-008 苏州德龙激光股份有限公司 关于第五届董事会第六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 苏州德龙激光股份有限公司（以下简称"公司"、"德龙激光"）第五届董事会 第六次会议于 2025 年 4 月 27 日在公司会议室以现场结合通讯的方式召开，会议 通知已于 2025 年 4 月 17 日通过通讯方式送达各位董事。本次会议由董事长赵裕 兴先生主持，应到董事 8 人，实到董事 8 人。本次会议的召集、召开符合有关法 律、法规及规章制度和《公司章程》的有关规定。 二、董事会会议审议情况 1、 审议通过《关于 2024 年度总经理工作报告的议案》 表决结果：8 票同意，0 票反对，0 票弃权。 2、 审议通过《关于 2024 年度董事会工作报告的议案》 2024 年，公司董事会严格遵守《公司法》等法律法规及《公司章程》《董事 会议事规则》等规章制度的规定，认真贯彻执行股东大会审议通过的各项决议， 积极推进董事会决议 ...

Financial Performance - The net profit attributable to shareholders for 2024 was a loss of RMB 34,501,101.02, indicating a negative profit situation that does not allow for profit distribution[6]. - As of December 31, 2024, the company's undistributed profits amounted to RMB 43,807,490.91[6]. - The board of directors has resolved not to distribute profits or increase capital reserves for the year 2024[6]. - The company's operating revenue for 2024 reached ¥715,191,631.87, representing a year-on-year increase of 22.93% compared to ¥581,808,798.56 in 2023[21]. - The net profit attributable to shareholders of the listed company decreased by 188.35% to -¥34,501,101.02 in 2024, down from ¥39,051,094.97 in 2023[21]. - The basic earnings per share for 2024 was -¥0.33, a decline of 186.84% from ¥0.38 in 2023[22]. - The net cash flow from operating activities for 2024 was -¥48,577,499.15, compared to -¥5,631,030.57 in 2023[21]. - The total assets of the company as of the end of 2024 were ¥1,834,177,292.67, reflecting a 5.11% increase from ¥1,744,988,810.40 in 2023[21]. - The company reported a significant increase in impairment losses for long-term equity investments and various receivables in 2024, impacting net profit[23]. Research and Development - Research and development expenses accounted for 18.24% of operating revenue in 2024, an increase of 0.42 percentage points from 17.82% in 2023[23]. - The company plans to continue high levels of R&D investment and product development to enhance market service and innovation[24]. - The company achieved a total R&D investment of ¥130,422,991.73 in the current year, representing a 25.78% increase compared to ¥103,688,902.61 in the previous year[79]. - R&D investment accounted for 18.24% of total revenue, an increase of 0.42 percentage points from 17.82% in the previous year[79]. - The company holds a total of 245 valid patents, including 56 invention patents and 189 utility model patents, as well as 180 software copyrights[76]. - During the reporting period, the company applied for 70 invention patents and obtained 16, bringing the cumulative total to 341 applications and 54 granted[77]. Market Position and Strategy - The company operates in the high-end equipment manufacturing sector, specifically in laser processing equipment, with a focus on precision applications across various industries[53]. - The company has established a strong market position in the high-end industrial application laser equipment segment, with fewer competitors in the precision micro-processing field[59]. - The company is focusing on solid-state battery technology, introducing new laser processing equipment for solid-state battery manufacturing[38]. - The company is expanding its international presence by establishing wholly-owned subsidiaries in Japan, the USA, Australia, and Germany to enhance brand influence and local market penetration[152]. - The company aims to enhance its market influence and product market share, focusing on semiconductor, display, new electronics, and new energy applications[152]. Risks and Challenges - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[8]. - There are no violations of decision-making procedures regarding external guarantees[9]. - The company faces risks related to significant performance declines or losses, but its core business and competitive advantages have not undergone major adverse changes[98]. - The high-end laser equipment manufacturing industry is characterized by technological and capital intensity, facing multiple operational risks including cyclical fluctuations and supply chain dependencies[99]. - The company is exposed to risks related to the import of core raw materials, particularly laser components, which could be affected by international trade conditions[105]. Corporate Governance - The company confirmed that all board members attended the board meeting[6]. - The company has established stable partnerships with numerous well-known clients, which solidifies its business development foundation[97]. - The company held 6 board meetings in the year, all conducted via communication methods[183]. - The supervisory board held 5 meetings, effectively supervising the company's operations and protecting shareholder interests[159]. - The company disclosed 55 temporary announcements and 4 regular reports in 2024, ensuring transparency and compliance with disclosure regulations[160]. Future Outlook - The company provided guidance for Q4 2023, expecting revenue to be between $1.6 billion and $1.7 billion, indicating a potential growth of 10% to 13%[170]. - Overall, the company remains optimistic about future growth, with a long-term target of achieving $10 billion in revenue by 2025[170]. - The company plans to enhance its digital marketing strategy, expecting a 30% increase in customer engagement[173]. - The company plans to conduct cash management using part of the idle raised funds[181]. - The company aims to expand upstream and downstream in the semiconductor business, enhancing its market share in laser processing equipment by providing complete solutions[154].

证券代码：688170 证券简称：德龙激光 公告编号：2025-011 苏州德龙激光股份有限公司 关于 2024 年度拟不进行利润分配的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 因苏州德龙激光股份有限公司（以下简称"公司"、"德龙激光"）2024 年 归属于上市公司股东净利润为负值，综合考虑公司盈利状况、发展战略、发展规 划及资金需求，为保障公司持续、稳定、健康发展，更好地维护全体股东的长远 利益，根据相关法律法规以及《公司章程》等规定，2024 年度拟不进行利润分 配，也不进行资本公积金转增股本。 本次利润分配方案已经公司第五届董事会第六次会议、第五届监事会第 六次会议审议通过，尚需提交公司 2024 年年度股东大会审议。 公司不触及《上海证券交易所科创板股票上市规则》（以下简称《科创 板股票上市规则》）第 12.9.1 条第一款第（八）项规定的可能被实施其他风险警 示的情形。 一、 利润分配方案内容 （一）利润分配方案的具体内容 经容诚会计师事务所（特殊普通合伙）审计，公司 2024 年度合并报 ...

证券代码：688170 证券简称：德龙激光 公告编号：2025-012 苏州德龙激光股份有限公司 关于提请股东大会授权董事会办理以简易程序向 特定对象发行股票相关事宜的公告 一、 本次授权事项概述 根据《上市公司证券发行注册管理办法》《上海证券交易所上市公司证券发 行上市审核规则》《上海证券交易所上市公司证券发行与承销业务实施细则》等 相关规定，苏州德龙激光股份有限公司（以下简称"德龙激光"、"公司"）于 2025 年 4 月 27 日召开第五届董事会第六次会议，审议通过了《关于提请股东大 会授权董事会办理以简易程序向特定对象发行股票相关事宜的议案》，董事会同 意提前股东大会授权董事会决定公司向特定对象发行融资总额不超过人民币 3 亿元且不超过公司最近一年末净资产 20%的股票，授权期限为自公司 2024 年度 股东大会审议通过之日起至公司 2025 年度股东大会召开之日止。 二、 本次授权具体内容 本次提请股东大会授权事宜包括以下内容： （一）确认公司是否符合以简易程序向特定对象发行股票条件 授权董事会根据《中华人民共和国公司法》《中华人民共和国证券法》《上 市公司证券发行注册管理办法》等有关法律法规和规范 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥99,165,075.14, a decrease of 14.26% compared to ¥115,657,779.36 in the same period last year[3] - The net profit attributable to shareholders was a loss of ¥16,470,410.56, worsening from a loss of ¥7,263,464.76 year-on-year[3] - The weighted average return on net assets was -1.35%, a decrease of 0.79 percentage points from -0.56%[3] - The basic and diluted earnings per share were both -¥0.16, compared to -¥0.07 in the same period last year[3] - Total operating revenue for Q1 2025 was ¥99,165,075.14, a decrease of 14.3% compared to ¥115,657,779.36 in Q1 2024[15] - Net profit for Q1 2025 was a loss of ¥16,470,410.56, compared to a loss of ¥7,263,464.76 in Q1 2024, representing a deterioration of 126.3%[16] - The total comprehensive loss for Q1 2025 was ¥16,578,062.19, compared to a loss of ¥7,245,782.96 in Q1 2024, reflecting increased financial challenges[16] Cash Flow - The net cash flow from operating activities improved to ¥20,943,240.54, compared to a negative cash flow of ¥34,202,623.08 in the previous year[3] - Cash flow from operating activities for Q1 2025 was ¥20,943,240.54, a significant improvement from a negative cash flow of ¥34,202,623.08 in Q1 2024[18] - Cash flow from investing activities for Q1 2025 was a net outflow of ¥56,764,895.01, compared to a net inflow of ¥28,749,485.60 in Q1 2024[19] - The cash and cash equivalents at the end of Q1 2025 stood at ¥194,579,409.20, down from ¥515,478,331.54 at the end of Q1 2024[19] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,779,045,772.42, down 3.01% from ¥1,834,177,292.67 at the end of the previous year[4] - As of March 31, 2025, the company's total current assets amounted to approximately CNY 1.35 billion, a decrease of about 4.1% from CNY 1.41 billion on December 31, 2024[11] - The company's total assets were CNY 1.78 billion, down from CNY 1.83 billion, indicating a decrease of approximately 3.0%[12] - Total liabilities decreased to CNY 563.28 million from CNY 601.83 million, a decline of about 6.4%[13] - The equity attributable to shareholders decreased to CNY 1.22 billion from CNY 1.23 billion, a reduction of about 4.7%[13] Research and Development - Research and development expenses totaled ¥30,778,553.04, representing 31.04% of operating revenue, an increase of 5.95 percentage points from 25.09%[4] - Research and development expenses for Q1 2025 were ¥30,778,553.04, up from ¥29,014,771.94 in Q1 2024, indicating a focus on innovation[15] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 5,681[8] - The largest shareholder held 22.97% of the shares, with a total of 23,745,000 shares[8] - The company has not reported any changes in major shareholders or their participation in margin trading[9] Other Information - The company reported non-recurring gains and losses totaling ¥3,447,263.70 for the period[6] - There are no significant reminders or additional important information regarding the company's operational situation during the reporting period[10] - The company recorded a foreign exchange loss of ¥107,651.63 in Q1 2025, contrasting with a gain of ¥17,681.80 in Q1 2024[16] - The company reported a significant increase in contract liabilities to CNY 194.07 million from CNY 172.93 million, an increase of approximately 12.1%[12] - Total operating costs for Q1 2025 were ¥122,989,001.71, slightly down from ¥124,415,481.66 in Q1 2024[15] - Accounts receivable decreased to CNY 201.79 million from CNY 269.76 million, a reduction of about 25.2%[11] - Inventory increased to CNY 552.01 million from CNY 506.07 million, reflecting an increase of approximately 9.1%[11]

二、前10名无限售条件股东持股情况 一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.3300 | 0.3800 | -186.84 | 0.7100 | | 每股净资产（元） | 11.92 | 12.65 | -5.77 | 12.67 | | 每股公积金(元) | 9.17 | 9.16 | 0.11 | 9.16 | | 每股未分配利润(元) | 1.58 | 2.22 | -28.83 | 2.25 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 7.15 | 5.82 | 22.85 | 5.68 | | 净利润(亿元) | -0.35 | 0.39 | -189.74 | 0.67 | | 净资产收益率(%) | -2.73 | 2.99 | -191.3 | 6.34 | 数据四舍五入，查看更多财务数据>> 前十大流通股东累计持有： 3338.08万股，累计占流通股比： ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688170 证券简称：德龙激光 公告编号：2025-004 苏州德龙激光股份有限公司 ● 本次股票上市流通日期为2025年4月29日。 一、本次上市流通的限售股类型 根据中国证券监督管理委员会2022年3月4日出具的《关于同意苏州德龙激光股份有限公司首次公开发行 股票注册的批复》（证监许可〔2022〕460号），德龙激光获准以首次公开发行方式向社会公众发行人 民币普通股（A股）2,584.00万股，并于2022年4月29日在上海证券交易所科创板上市，发行完成后总股 本为10,336.00万股，其中有限售条件流通股82,329,903股，占公司发行后总股本的79.6535%，无限售条 件流通股21,030,097股，占公司发行后总股本的20.3465%。 本次上市流通的限售股为公司首次公开发行限售股，限售股股东数量为1名，限售期为自首次公开发行 并上市之日起36个月，本部分限售股股东对应的股份数量合计为23,745,000股，占公司发行完成后总股 本的22.97%。该限售股将于2025年4月29日起上市流通。 二、本次上市流通的限售股形成后至今公司股 ...